Effects of salmeterol on sleeping oxygen saturation in chronic obstructive pulmonary disease.

Respiration; international review of thoracic diseases

Volumn 79, Issue 6, 2010, Pages 475-481

  Ryan, Silke ^a   Doherty, Liam S ^b   Rock, Clare ^b   Nolan, Geraldine M ^b   McNicholas, Walter T ^b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; DRUG DERIVATIVE; OXYGEN; SALBUTAMOL; SALMETEROL;

AGED; ARTICLE; BLOOD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG DIFFUSION CAPACITY; LUNG VOLUME; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SLEEP; SPIROMETRY;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; AGED; ALBUTEROL; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; OXYGEN; POLYSOMNOGRAPHY; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SLEEP; SPIROMETRY;

EID: 77953807996     PISSN: None     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000235619     Document Type: Article

References (0)